1. Home
  2. TK vs ALVO Comparison

TK vs ALVO Comparison

Compare TK & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teekay Corporation

TK

Teekay Corporation

HOLD

Current Price

$12.93

Market Cap

925.8M

ML Signal

HOLD

Logo Alvotech

ALVO

Alvotech

HOLD

Current Price

$4.98

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TK
ALVO
Founded
1973
2013
Country
Bermuda
Luxembourg
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
925.8M
1.0B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
TK
ALVO
Price
$12.93
$4.98
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$8.00
AVG Volume (30 Days)
498.3K
1.0M
Earning Date
05-13-2026
05-06-2026
Dividend Yield
15.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$13.28
Revenue Next Year
N/A
$18.63
P/E Ratio
$13.43
$18.20
Revenue Growth
N/A
N/A
52 Week Low
$7.80
$2.94
52 Week High
$14.38
$9.25

Technical Indicators

Market Signals
Indicator
TK
ALVO
Relative Strength Index (RSI) 59.09 71.99
Support Level $12.09 $4.67
Resistance Level $13.09 $5.46
Average True Range (ATR) 0.48 0.28
MACD 0.02 0.09
Stochastic Oscillator 70.04 72.87

Price Performance

Historical Comparison
TK
ALVO

About TK Teekay Corporation

Teekay Corp Ltd provides international crude oil marine transportation and other marine services. It also offers offshore oil production, storage, and offloading services, under long-term, fixed-rate contracts. The company has two primary lines of business: Marine services and tankers. It manages these businesses for the benefit of all stakeholders. The company serves energy and utility companies, oil traders, large oil and LNG consumers, petroleum product producers, government agencies, and various other entities that depend upon marine transportation.

About ALVO Alvotech

Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.

Share on Social Networks: